- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04146688
Nonverbal Communication in Aged People (MAMUS)
Nonverbal Communication in Aged People With and Without Neurodegenerative Disease: Study of Sensorimotor Synchronization to Music
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lille, France
- Hôpital les Bateliers, CHU
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Cases : Patients with neurodegenerative disease (AD or related disease)
- Native French Language
- Corrected auditory and/or visual deficiency
- Right-handed
- Image rights consent signed by the patient Controls: People with no neuropathological disease
- Native French Language
- Corrected auditory and/or visual deficiency
- Right-handed
- Image rights consent signed by the control
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Patients with neurodegenerative disease
Patients with neurodegenerative disease (AD or related disease)
|
The SSM is measured with an innovative tool (Music Balance Board) developed at the University of Ghent (Belgium) and specially designed to record the movements of the elderly in a natural and comfortable position This chair is equipped with a tablet and sensors that record the movements of the hand and body during the SSM to a musical sequence.
The analysis will focus on the difference between the participant's striking and the beat of the music measured using this chair.
|
|
Active Comparator: People with no neuropathological disease
|
The SSM is measured with an innovative tool (Music Balance Board) developed at the University of Ghent (Belgium) and specially designed to record the movements of the elderly in a natural and comfortable position This chair is equipped with a tablet and sensors that record the movements of the hand and body during the SSM to a musical sequence.
The analysis will focus on the difference between the participant's striking and the beat of the music measured using this chair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
measure of consistency (oppositive of variability)
Time Frame: Baseline, before SMS task
|
measure of consistency (oppositive of variability) of the response corresponding to the length of a vector going from 0 (bad) to 1(very good response). This measure is completed by another measure of asynchrony. |
Baseline, before SMS task
|
|
measure of asynchrony.
Time Frame: Baseline, before SMS task
|
The asynchrony assess the accuracy of the movements in ms.
If the participant anticipated the tap relative to the musical beat, the value is negative, if the participant delayed the tap, the value is positive.
A perfect tap is 0 in this case
|
Baseline, before SMS task
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of the Music Balance Board (cf. primary outcome) during music in the presence of a real experimenter
Time Frame: Baseline, before SMS task
|
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
|
Baseline, before SMS task
|
|
Measurement of the Music Balance Board (cf. primary outcome) during music in the presence of a virtual experimenter;
Time Frame: after SMS task, an average after 45 min
|
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
|
after SMS task, an average after 45 min
|
|
Measurement of the Music Balance Board (cf. primary outcome) during metronome in the presence of a real experimenter
Time Frame: after SMS task, an average after 45 min
|
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
|
after SMS task, an average after 45 min
|
|
Measurement of the Music Balance Board (cf. primary outcome) during metronome in the presence of a virtual experimenter.
Time Frame: after SMS task, an average after 45 min
|
measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV)
|
after SMS task, an average after 45 min
|
|
Decoding of non-verbal behaviors during the synchronization task
Time Frame: after SMS task, an average after 45 min
|
Decoding of non-verbal behavior during the synchronization task (rhythmic movements of the head, lips and lower limbs, visual contact) in duration (duration of the behavior/duration of the Condition expressed in seconds) by blind evaluators in the membership group.
|
after SMS task, an average after 45 min
|
|
Intensity of body movements (quantity of motion)
Time Frame: after SMS task, an average after 45 min
|
Intensity of body movements (quantity of motion) recorded by the motion sensors connected to the chair on which the patient sits. recorded during the SSM test and a filmed interview |
after SMS task, an average after 45 min
|
|
STAI Anxiety Scale Score
Time Frame: through study completion, an average of 2 hours
|
The State-Trait Anxiety Inventory (STAI) is a self-questionnaire, developed by Spielberger (7) and validated in French.
It has 20 questions, assessing the subject's usual emotional state.
A score is calculated, ranging from 20 to 80, a high score indicating the presence of anxiety.
|
through study completion, an average of 2 hours
|
|
Decoding of the frequency (number of behaviors / duration of the condition) of the facial expressions
Time Frame: through study completion, an average of 2 hours
|
the facial expressions based on videoscopic recordings of the synchronization task and a short interview (5min) by blind evaluators of the home group.
|
through study completion, an average of 2 hours
|
|
Scale of Assessment of Daily Activities
Time Frame: through study completion, an average of 2 hours
|
The ADLs used measure of functional ability is the Katz Activities of Daily Living Scale (Katz et al., 1963; Katx, 1983).
In this scale, the set of tasks assessed are bathing, dressing, transferring, using the toilet, continence, and eating.
|
through study completion, an average of 2 hours
|
|
Scale of Instrumental Activities of Daily Living
Time Frame: through study completion, an average of 2 hours
|
The Lawton IADL Scale takes approximately 10 to 15 minutes to administer.
It contains 8 items that are rated with a summary score from 0 (low functioning) to 8 (high functioning)
|
through study completion, an average of 2 hours
|
|
Neuropsychiatric Inventory (NPI) subscales Impact on the workload of the caregiver.
Time Frame: through study completion, an average of 2 hours
|
total NPI score is defined as the sum of the individual category scores.
Higher scores on NPI indicate a more frequent and/or severe presence of neuropsychiatric behavioral changes.
The following domains will be included in the subscore: Depression/Dysphoria, Anxiety, Apathy/Indifference, Irritability/Lability, Agitation/Aggression, and Disinhibition.
|
through study completion, an average of 2 hours
|
|
mini-mental state examination (MMSE) score
Time Frame: through study completion, an average of 2 hours
|
The Mini-Mental State Examination (MMSE) is a brief 30-point questionnaire test that is used to screen for cognitive impairment. Scores on a scale range from 0 - 30. Scores 23 and below are indicative of problems. |
through study completion, an average of 2 hours
|
|
Concentration of cortisol from saliva samples
Time Frame: Once, at Day 1, baseline
|
measure the saliva cortisol before and after the synchronization task
|
Once, at Day 1, baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: François Puissieux, MD,PhD, University Hospital, Lille
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017_35
- 2017-A03543-50 (Other Identifier: ID-RCB number, ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
Johns Hopkins UniversityNational Institutes of Health (NIH)Not yet recruiting
-
Xuanwu Hospital, BeijingEnrolling by invitation
-
University Hospital, GrenobleRecruiting
-
Fujian Medical University Union HospitalRecruitingAlzheimer s DiseaseChina
Clinical Trials on Music Balance Board
-
Riphah International UniversityCompleted
-
Lebanese German UniversityCompleted
-
Shirley Ryan AbilityLabCompletedParkinson's DiseaseUnited States
-
Cairo UniversityCompletedDiplegic Cerebral Palsy | Balance Board | Standing BalanceEgypt
-
University Hospital of FerraraCompletedMultiple Sclerosis | Postural BalanceItaly
-
Hitit UniversityCompletedMotor Learning | Virtual Reality Based Therapy | Agility | Ankle DorsiflexionTurkey (Türkiye)
-
Riphah International UniversityCompletedHearing Impaired ChildrenPakistan
-
Cairo UniversityCompletedOsteoporosis | MastectomyEgypt
-
University of British ColumbiaCompletedBelow Knee AmputationCanada